CME/CE Courses New

Featured Courses

Emerging Gene Therapies in the Fight Against ALS | myCME

0.75 CME CE: In part 3 of this series, faculty discuss best practices for navigating the clinical trial landscape of ALS gene therapies. Exp 4/12/23

New Advances in Diagnosis and Management of NASH | myCME

1.00 CME: Latest information on how to screen for, diagnose, and risk stratify NASH and plan patient-personalized multidisciplinary treatment. Exp 4/13/23

Upstream Mediators With Next-Generation Biologics | myCME

0.75 CME: Provides clinicians with an understanding of the unmet needs in severe asthma, the alarmin pathway, and novel biologic therapies. Exp 7/29/23

Minimizing Stigma in Obesity Care | myCME

0.50 CME CE: This audio activity on obesity provides practical strategies to improve communication and discusses keeping patients engaged. Exp 1/15/23

Maternal Alloimmunization and Hemolytic Disease of the Fetus and Newborn | myCME

1.50 CME CE: Interactive course discusses the pathogeneses of MA and HDFN, traditional management, and potential to integrate FcRn inhibitors. Exp 7/27/23

Lung Consequences of Alpha-1 Antitrypsin Deficiency | myCME

1.00 CME CE: Interactive, case-based approach to diagnosis and appropriate management of individuals with Alpha-1 antitrypsin deficiency (AATD). Exp 6/9/23

Endometrial Cancer Treatment and Outcomes | myCME

1.00 CME: Experts debate and discuss molecular testing, clinical data, treatment selection, and patient management in endometrial cancer. Exp 2/24/23

A Multidisciplinary Approach to Cervical Cancer Treatment | myCME

1.50 CME CE: New therapies, new sequencing and management strategies, and a critical need for expert guidance are shifting CC treatment. Exp 4/23/23